Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Amicus Therapeutics (FOLD)
NASDAQ:FOLD
Amicus (FOLD) Ownership - Who Owns Amicus?
898 Followers
Amicus (FOLD) Ownership Overview
30.57% Insiders
33.39% Mutual Funds
18.68% Other Institutional Investors
17.36% Public Companies and
Individual Investors
The ownership structure of Amicus (FOLD) stock is a mix of institutional, retail and individual investors. Approximately 52.07% of the company’s stock is owned by Institutional Investors, 30.57% is owned by Insiders and 17.36% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 05, 2024 | Bradley Campbell President & Ceo,director | Sold | $75000 |
| May 03, 2024 | Bradley Campbell President & Ceo,director | Sold | $75450 |
| Apr 03, 2024 | Bradley Campbell President & Ceo,director | Sold | $87450 |
| Mar 06, 2024 | Margaret Mcglynn Director | Sold | $200175 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | Bought | $155708 | |
| Mar 31, 2024 | Bought | $194240 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 28,057,456 | Institution | 9.47% | 274,963,069 | |
| 27,200,923 | Institution | 9.18% | 266,569,045 | |
| 24,707,688 | Institution | 8.34% | 242,135,342 | |
| 20,724,424 | Insider | 7.00% | 203,099,355 | |
| 13,772,376 | Institution | 4.65% | 134,969,285 | |
| 12,831,654 | Institution | 4.33% | 125,750,209 | |
| 9,916,813 | Institution | 3.35% | 97,184,767 | |
| 6,682,398 | Institution | 2.26% | 65,487,500 | |
| 6,538,562 | Institution | 2.21% | 64,077,908 | |
| 5,340,622 | Institution | 1.80% | 52,338,096 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 24,707,688 | Institution | 8.34% | 242,135,342 | |
| 13,772,376 | Institution | 4.65% | 134,969,285 | |
| 9,916,813 | Institution | 3.35% | 97,184,767 | |
| 6,538,562 | Institution | 2.21% | 64,077,908 | |
| 5,340,622 | Institution | 1.80% | 52,338,096 | |
| 3,492,476 | Institution | 1.18% | 34,226,265 | |
| 3,059,475 | Institution | 1.03% | 29,982,855 | |
| 2,671,415 | Institution | 0.90% | 26,179,867 | |
| 2,612,352 | Institution | 0.88% | 25,601,050 | |
| 2,469,820 | Institution | 0.83% | 24,204,236 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,361,469 | Institution | 3.16% | 91,742,396 | |
| 7,481,371 | Institution | 2.53% | 73,317,436 | |
| 7,134,154 | Institution | 2.41% | 69,914,709 | |
| 4,725,643 | Institution | 1.60% | 46,878,379 | |
| 4,258,078 | Institution | 1.44% | 41,729,164 | |
| 3,923,179 | Institution | 1.32% | 38,447,154 | |
| 2,586,470 | Institution | 0.87% | 25,347,406 | |
| 2,136,358 | Institution | 0.72% | 20,936,308 | |
| 1,241,553 | Institution | 0.42% | 12,316,206 | |
| 1,111,625 | Institution | 0.38% | 11,016,204 |
FAQ
Who Owns Amicus Therapeutics (FOLD)?
According to the latest TipRanks data, approximately 18.68% of the company's stock is held by institutional investors, 30.57% is held by insiders, and 17.36% is held by retail investors.
What percentage of Amicus Therapeutics (FOLD) stock is held by institutional investors?
According to the latest TipRanks data, approximately 18.68% of Amicus Therapeutics (FOLD) stock is held by institutional investors.
What percentage of Amicus Therapeutics (FOLD) stock is held by retail investors?
According to the latest TipRanks data, approximately 17.36% of Amicus Therapeutics (FOLD) stock is held by retail investors.
Who owns the most shares of Amicus Therapeutics (FOLD)?
Joseph Edelman owns the most shares of Amicus Therapeutics (FOLD).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.